Buprenorphine And Naloxone Film
Product Images NDC 67296-2063

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-2063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 01)

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 01)
This text provides instructions for using Buprenorphine and Naloxone Sublingual Film, including how to place the films under the tongue or inside the cheek, storing conditions, and dosage information. It also mentions the content of each film and the necessity to keep them away from children due to their emergency medical care requirement in case of accidental ingestion. The text contains details about the product such as its NDC number, the number of sublingual films in a package, and the active ingredients present.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 02)

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 02)
This is a description of how to take Buprenorphine and Naloxone Sublingual Film. The instructions include placing the film under the tongue, avoiding letting the films touch, keeping them in place until fully dissolved, and storing them at room temperature. It is important to follow the prescribed dosage and keep the film out of the reach of children as accidental ingestion may require emergency medical care. Each sublingual film contains 4 mg of buprenorphine and 1 mg of naloxone. Additionally, it is mentioned not to cut, chew, or swallow the film. The packaging includes 30 pouches with each containing 1 sublingual film. The text also provides information for pharmacists on how to dispense the medication.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 03)

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 03)
This text contains information about a medication called Buprenorphine and Naloxone, which is a sublingual film used for opioid addiction treatment. It includes instructions for usage and warnings about accidental ingestion by children, as well as the necessity for emergency medical care in such cases. The text also mentions storage conditions and a unique identification number for the product.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 04)

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 04)
This is a description of a medication labeled as "Buprenorphine and Naloxone Sublingual Film" by Mylan. The product comes in a film form for sublingual administration (placing under the tongue). It contains specific dosages of buprenorphine and naloxone. The package has an NDC code, and there are warnings about not cutting, chewing, or swallowing the film. It also includes dosage information for adults and children. The label provides details on the equivalent amount in milligrams of buprenorphine and naloxone in the film. Additionally, there is information about the expiration date, lot number, and GTIN.*
FDA Label Image

Buprenorphine Hydrochloride Structrual Formula (Image 05)

FDA Label Image

Naloxone Hydrochloride Structural Formula (Image 06)

FDA Label Image

Instructions For Use Figure 1 (Image 07)

FDA Label Image

Instructions For Use Figure 2 (Image 08)

FDA Label Image

Instructions For Use Figure 3 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.